SOPHiA GENETICS (SOPH) Accounts Payables (2020 - 2025)
Historic Accounts Payables for SOPHiA GENETICS (SOPH) over the last 6 years, with Q3 2025 value amounting to $6.1 million.
- SOPHiA GENETICS's Accounts Payables rose 318.62% to $6.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.1 million, marking a year-over-year increase of 318.62%. This contributed to the annual value of $5.2 million for FY2024, which is 317.2% down from last year.
- SOPHiA GENETICS's Accounts Payables amounted to $6.1 million in Q3 2025, which was up 318.62% from $7.7 million recorded in Q2 2025.
- In the past 5 years, SOPHiA GENETICS's Accounts Payables registered a high of $8.8 million during Q3 2021, and its lowest value of $4.6 million during Q1 2025.
- Over the past 5 years, SOPHiA GENETICS's median Accounts Payables value was $6.2 million (recorded in 2022), while the average stood at $6.4 million.
- Its Accounts Payables has fluctuated over the past 5 years, first crashed by 3592.88% in 2022, then skyrocketed by 4532.98% in 2025.
- Quarter analysis of 5 years shows SOPHiA GENETICS's Accounts Payables stood at $6.7 million in 2021, then decreased by 8.25% to $6.2 million in 2022, then decreased by 12.78% to $5.4 million in 2023, then decreased by 3.17% to $5.2 million in 2024, then rose by 16.02% to $6.1 million in 2025.
- Its Accounts Payables was $6.1 million in Q3 2025, compared to $7.7 million in Q2 2025 and $4.6 million in Q1 2025.